Analysis of the Immune Response against Tetanus Toxoid: Enumeration of Specific T Helper Cells by the Elispot Assay

https://doi.org/10.1078/0171-2985-00131Get rights and content

Summary

Tetanus toxoid (TT) is an antigen known to induce strong T cell specific immune responses in humans after vaccination. Here we have used the Elispot assay to assess the number of TT-specific Interferon-g (IFN-g) secreting T cells present in individuals and monitored the number of TT specific T cells present in the donors for more than two years. In each of the 22 healthy volunteers tested, TT-specific T cells could be detected. Six out of 7 repetitively tested donors showed a remarkably constant number of TT-specific IFN-g secreting T cells over several months, whereas one donor demonstrated a transient increase during a flu-like infection. Three healthy donors received TT booster-immunizations and showed significant increases in the number of TT-specific IFN-g secreting T cells which reached peak levels by 4 weeks after vaccination. Depletion of either CD4+ T cells, CD8+ T cells or CD16+/CD56+ T cells by immunomagnetic separation demonstrated that TT-specific IFN-g secretion is mediated exclusively by CD4+ T cells. In addition, HLA class-I and -II blocking studies showed that IFN-g production is performed by HLA class-II restricted cells. Our data show that the Elispot assay can be reliably used to assess the number of TT-specific CD4+ IFN-g producing cells (i.e. probably T helper cells) and therefore maybe also useful for the assessment of reactions to other helper antigens.

References (18)

There are more references available in the full text version of this article.

Cited by (39)

  • A simple method for measuring immune complex-mediated, Fc gamma receptor dependent antigen-specific activation of primary human T cells

    2018, Journal of Immunological Methods
    Citation Excerpt :

    We argue that this mode of presentation may represent a more accurate model of antigen responses in vivo; where ICs formation is the norm. This makes the assay more robust and relevant for the study of broad, pro-inflammatory responses than similar in vitro assays relying on uncoated TT antigen (Mayer et al., 2002; Piersma et al., 2006). Comparing an autologous DC:T cell TT-IC dependent T cell activation protocol with the PBMC based protocol, TT-IC led to comparable T cell activation in both systems.

  • Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs

    2017, Vaccine
    Citation Excerpt :

    Our observed cell- and antibody-mediated responses are not surprising, as the anti-TT response has been reported to be a mixture between Th1 and Th2 [21,22]. Humans i.m. immunized against alum-adjuvanted TT showed a strong CD4+ T-cell response [23], whereas we demonstrated an increased amount of CTLs within the pools of IFN-γ and TNF-α producing T-cells. This discrepancy likely reflects the differences in adjuvants and delivery route.

  • Vaccine Immunology

    2017, Plotkin's Vaccines
View all citing articles on Scopus
View full text